SiliconInvestor
     Advanced Search   [ sign in ]

sponsor
Sponsor

 Biotech / Medical : InterMune (nasdaq)ITMN

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Biotech Jim who wrote (487)5/16/2012 8:00:21 PM
From: ghmmRead Replies (1) of 500
 
Speaking of Fibrogen here is a link to the changes in their Phase 2 study (just got the update on my RSS feed). I don't know when they started/will start cohort 2. I never count on the clinicaltrials.gov completion date (they have 12/2013). So assuming they wait for that to finish before pursing a Phase 3 and we're looking at several years behind ITMN.

If it wasn't open label and the results continued to be promising maybe they'd have a shot with exceptional Phase 2 but that seems unlikely.

EDIT forgot link
clinicaltrials.gov 
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.